The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; Sanofi; SERVIER; Takeda; TG Therapeutics; Verastem
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; SERVIER; Verastem
Duration of response to loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma by demographic and clinical characteristics: Subgroup analyses from LOTIS 2.
 
Paolo Caimi
Consulting or Advisory Role - ADC Therapeutics; Amgen; Genentech; Kite, a Gilead Company; Seagen; TG Therapeutics; Verastem
Speakers' Bureau - Celgene
Research Funding - ADC Therapeutics; Genentech
 
Weiyun Z. Ai
Consulting or Advisory Role - Acrotech Biopharma; ADC Therapeutics; BeiGene; Kirin Pharmaceuticals; Kymera; Nurix; Seagen; Walking Fish Therapeutics
Research Funding - Nurix
 
Juan Pablo Alderuccio
Consulting or Advisory Role - ADC Therapeutics; Agios (I); FORMA Therapeutics (I); Foundation Medicine (I); Inovio Pharmaceuticals (I); Puma Biotechnology (I)
Expert Testimony - OncLive; Oncology Information Group
 
Kirit Ardeshna
Other Relationship - Autolus; Celgene
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - ADC Therapeutics; Cellerant Therapeutics; Incyte; Janssen Research & Development; MedImmune; Pharmacyclics; Puma Biotechnology (I); Verastem
Speakers' Bureau - AstraZeneca; Celgene; Genzyme
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Brian T. Hess
Consulting or Advisory Role - ADC Therapeutics; Karyopharm Therapeutics
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Genentech; Incyte; Janssen; Karyopharm Therapeutics; Kite/Gilead; MEI Pharma; Molecular Templates; MorphoSys; Pharmacyclics; Pharmacyclics; Roche; Teva
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Celgene (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Abbvie; Celgene; Genentech/Roche; Juno Therapeutics; Millennium; Seagen
 
John A. Radford
Stock and Other Ownership Interests - AstraZeneca (I); GlaxoSmithKline (I)
Honoraria - ADC Therapeutics; Takeda
Consulting or Advisory Role - Novartis; Seagen; Takeda
Speakers' Bureau - Novartis; Seagen; Takeda
Research Funding - Takeda
Travel, Accommodations, Expenses - ADC Therapeutics; Takeda
 
Melhem M. Solh
Speakers' Bureau - Abbvie; Amgen; Bristol-Myers Squibb; Seagen
Research Funding - Partner therapeutics
 
Anastasios Stathis
Consulting or Advisory Role - Bayer (Inst); Lilly (Inst)
Research Funding - ADC Therapeutics (Inst); Bayer (Inst); Cellestia Biotech (Inst); Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; PharmaMar
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Jay Marshall Feingold
Employment - ADC Therapeutics
Leadership - ADC Therapeutics; ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to the development of our products
 
David Ungar
Employment - ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
 
Yajuan Qin
Employment - ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
 
Shui He
Employment - ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
 
Carmelo Carlo-Stella
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Incyte; Janssen Oncology; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Incyte; Karyopharm Therapeutics; Roche; Sanofi
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Janssen; Roche; Takeda